Saskatchewan Health Research Foundation   Report issue

Foundation Phase 2 Phase 4
Founded: Saskatoon Canada (1979)

Organization Overview

First Clinical Trial
2010
NCT01234506
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Saskatchewan Health Research Foundation

Active Ingredients

Drugs in Phase 4 Trials (1)

apixaban (eliquis) (1 trial)

Drugs in Phase 2 Trials (3)

secoisolariciresinol (3 trials)

vitamin d3 (1 trial)

whey protein (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dementia (Phase 2)

Inflammation (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 4